EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cancer cell-intrinsic mechanisms driving acquired immune tolerance

Ehsan Ghorani, Charles Swanton, Sergio A Quezada

Immunity · 2023-10 · 56 (10) · 2270-2295

DOI: 10.1016/j.immuni.2023.09.004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, 2023-10. Verfasst von Ehsan Ghorani und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Immunology and Immunotherapy Unit, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Medical Oncology, Impe…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 116-mal zitiert (Crossref) und nennt 365 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Medical Research Council, Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune evasion is a hallmark of cancer, enabling tumors to survive contact with the host immune system and evade the cycle of immune recognition and destruction. Here, we review the current understanding of the cancer cell-intrinsic factors driving immune evasion. We focus on T cells as key effectors of anti-cancer immunity and argue that cancer cells evade immune destruction by gaining control over pathways that usually serve to maintain physiological tolerance to self. Using this framework, we place recent mechanistic advances in the understanding of cancer immune evasion into broad categories of control over T cell localization, antigen recognition, and acquisition of optimal effector function. We discuss the redundancy in the pathways involved and identify knowledge gaps that must be overcome to better target immune evasion, including the need for better, routinely available tools that incorporate the growing understanding of evasion mechanisms to stratify patients for therapy and trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHumansImmune ToleranceT-LymphocytesImmunotherapyImmune Evasion

Stichwörter der Autor:innen

acquired tolerancecancer immune evasioncancer immunotherapy

Autor:innen und Institutionen

  • Cancer Immunology and Immunotherapy Unit, Department of Surgery and Cancer, Imperial College London, London, UK; Department of Medical Oncology, Imperial College London Hospitals, London, UK. Electronic address: e.ghora…
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK; Department of Onc…
  • Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Cancer Immunology Unit, Research Department of Hematology, University College London Cancer Institute, London,…

Förderung

  • Cancer Research UK
  • Medical Research Council
  • Department of Health
  • Wellcome Trust

Zitieren

APA

Ghorani, E., Swanton, C., & Quezada, S. A. (2023). Cancer cell-intrinsic mechanisms driving acquired immune tolerance. Immunity, 56(10), 2270-2295. https://doi.org/10.1016/j.immuni.2023.09.004

Vancouver

Ghorani E, Swanton C, Quezada SA. Cancer cell-intrinsic mechanisms driving acquired immune tolerance. Immunity. 2023;56(10):2270-2295. doi:10.1016/j.immuni.2023.09.004

BibTeX
@article{Ghorani2023,
  author = {Ghorani, Ehsan and Swanton, Charles and Quezada, Sergio A},
  title = {Cancer cell-intrinsic mechanisms driving acquired immune tolerance},
  journal = {Immunity},
  year = {2023},
  volume = {56},
  number = {10},
  pages = {2270--2295},
  doi = {10.1016/j.immuni.2023.09.004}
}
Kostenlos starten →